J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Annual Report 2022



The latest annual report of J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM) was published on 31 Mar 2022. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - JBCHEPHARM Annual Results

Amounts in INR

Total Revenue
24.24B
Gross Profit
15.59B
EBIT
4.74B
Net Tangible Assets
14.05B
Net Income
3.85B
Capital Expenditures
-628.7M

JBCHEPHARM Income Statement 2022 Annual Report

As per the latest Income Statement of JBCHEPHARM, the Net revenue increased by ₹3.817223B (19%) compared to the previous period. The operating income in 2022 decreased by ₹-152.47M (-3%). The net income as per the annual report was 3.85B which decreased by ₹-626.06M (-14%) compared to previous year.

Income Statement Report (2022/2021)

20222021
Total Revenue24.24B20.43B
Gross Profit15.59B13.2B
Operating Income4.74B4.9B
Income Before Tax5.05B5.97B
Net Income3.85B4.48B

Balance Sheet - JBCHEPHARM 2022 Annual Report

Read further: JBCHEPHARM Balance Sheet Detailed Analysis

The latest balance sheet from annual result of J. B. Chemicals & Pharmaceuticals Limited showed the company increased the cash on balance sheet by ₹278.59M (97%). The Net tangible assets of JBCHEPHARM on the balance sheet were at 14.05B which is ₹-3.14891B (-18%) less than previous annual report. The total stockholder equity also increased by ₹3.243982B (18%) compared to previous reporting period.

Balance Sheet Statement Report (2022/2021)

20222021
Cash565.44M286.86M
Total Assets26.07B 22.38B
Long Term Debt--
Total Liabilities4.69B 4.25B
Total Shareholder Equity21.34B18.1B
Net Tangible Assets14.05B17.2B

Cash Flow Statement - JBCHEPHARM 2022 Annual Report

The 2022 annual cash flow statement of J. B. Chemicals & Pharmaceuticals Limited showed that the net income decreased by ₹-626.06M (-14%) compared to previous reporting period. Also the capital expenditure of JBCHEPHARM decreased by ₹-150.97M (-32%).

As of 2022, the total cash from investing activities was 23.2M and total cash from financing activities was -1.38B.

Cash Flow Statement Report (2022/2021)

20222021
Net Income3.85B4.48B
Capital Expenditures-628.7M-477.73M
Dividends Paid-1.28B-732.4M
Total Cash From From Investing Activities23.2M-2.31B
Total Cash From From Financing Activities-1.38B-874.23M

J. B. Chemicals & Pharmaceuticals Limited Annual Report History

Income Statement

Income Statement history of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

31 Mar 202231 Mar 202131 Mar 202031 Mar 2019
Total Revenue24.24B20.43B17.75B16.43B
Cost Of Revenue8.65B7.23B6.53B6.19B
Gross Profit15.59B13.2B11.22B10.24B
Research Development----
Selling General Administrative5.66B4.26B4.07B3.82B
Non Recurring----
Other Operating Expenses4.46B3.36B3.31B3.28B
Total Operating Expenses19.5B15.53B14.57B13.85B
Operating Income4.74B4.9B3.18B2.58B
Total Other Income Expense Net306.07M1.07B306.75M287.38M
Ebit4.74B4.9B3.18B2.58B
Interest Expense-40.85M-67.43M-29.17M-34.14M
Income Before Tax5.05B5.97B3.49B2.87B
Income Tax Expense1.19B1.48B765M930.23M
Minority Interest44.9M37.05M25.01M28.03M
Net Income From Continuing Ops3.86B4.49B2.72B1.94B
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Charges----
Other Items----
Net Income3.85B4.48B2.72B1.93B
Net Income Applicable To Common Shares3.85B4.48B2.72B1.93B

Balance Sheet Statement

Balance Sheet Statement history of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

31 Mar 202231 Mar 202131 Mar 202031 Mar 2019
Cash565.44M286.86M290.08M353.97M
Short Term Investments1.06M--29.99M
Net Receivables5.98B4.19B3.61B3.25B
Inventory4.1B3.47B2.75B2.44B
Other Current Assets1.98B807.15M663.26M756.8M
Total Current Assets12.75B15.53B10.73B10.51B
Long Term Investments127.22M129.09M694.54M958.76M
Property Plant Equipment5.67B5.7B5.84B5.6B
Good Will574.59M574.59M531.4M531.4M
Intangible Assets6.71B321.05M300.92M233.78M
Other Assets241.56M133.85M105.27M88.97M
Deferred Long Term Asset Charges64.31M69.43M65.78M-
Total Assets26.07B22.38B18.21B17.92B
Accounts Payable2.24B1.87B1.68B1.17B
Other Current Liab1.01B943.67M1.04B970.34M
Other Liab644.56M742.7M680.74M648.39M
Minority Interest44.9M37.05M25.01M28.03M
Total Current Liabilities3.84B3.45B3.13B2.44B
Total Liab4.69B4.25B3.83B3.09B
Common Stock154.56M154.56M154.56M160.47M
Retained Earnings19.93B17.35B13.73B14.14B
Treasury Stock745.66M80.81M-41.06M-5.7M
Capital Surplus507.68M507.68M507.68M507.68M
Other Stockholder Equity745.66M80.81M-41.06M-5.7M
Total Stockholder Equity21.34B18.1B14.35B14.8B
Net Tangible Assets14.05B17.2B13.52B14.04B
Long Term Debt----

Cash Flow Statement

Cash Flow Statement history of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

31 Mar 202231 Mar 202131 Mar 202031 Mar 2019
Net Income3.85B4.48B2.72B1.93B
Depreciation722.41M683.27M659.93M548.76M
Change To Netincome146.37M-1.08B-723.22M-33.1M
Change To Account Receivables-2.93B-705.99M-114.95M-138.77M
Change To Liabilities528.35M464.75M521.06M-285.71M
Change To Inventory-625.14M-700.86M-309.12M-300.26M
Total Cash From Operating Activities1.7B3.15B2.76B1.94B
Capital Expenditures-628.7M-477.73M-729.68M-491.2M
Investments7B-2.24B912.56M103.73M
Other Cashflows From Investing Activities11.29M12.74M31.73M37.59M
Total Cashflows From Investing Activities23.2M-2.31B239.28M-276.65M
Dividends Paid-1.28B-732.4M-1.41B-207.94M
Net Borrowings-83.65M-78.34M-23.64M-500k
Other Cashflows From Financing Activities-24.57M-63.49M-18.65M-38.66M
Total Cash From Financing Activities-1.38B-874.23M-3.06B-1.56B
Effect Of Exchange Rate10k355k-129k-231k
Change In Cash340.7M-32.78M-63.9M108.99M